Literature DB >> 30274884

Pharmacist perceptions of the New Mexico pharmacist-performed tuberculosis testing program.

Stefanie J Logothetis, Matthew E Borrego, Melissa H Roberts, Amy Bachyrycz, Graham S Timmins, Bernadette Jakeman.   

Abstract

OBJECTIVE: This study evaluated pharmacists' perceptions of the New Mexico pharmacist-performed tuberculosis skin testing (PPTST) program.
METHODS: This cross-sectional study was conducted using a telephone survey. New Mexico pharmacists who completed the tuberculin skin test (TST) training from March 2011 to June 2016 were eligible for inclusion. Data collected included demographics, years since licensure, pharmacy setting and location, reasons for obtaining certification, training time, training quality, self-perceived competency after training, whether the participant was performing TSTs, number of tests performed, time required to administer or interpret the test, and reasons for not testing.
RESULTS: We attempted to contact all 209 pharmacists who completed the TST training during the evaluation period. Ninety-four of the 99 pharmacists contacted consented to participate (overall study response rate of 45%). The chain community pharmacy was the most common practice setting of respondents. After training completion, greater than 95% agreed or strongly agreed they felt confident in administering the TST. The percent of respondents working in New Mexico who were actively testing was 50.6%, with 42% of those pharmacists providing TSTs in small cities. Eleven pharmacists reported that they were performing TSTs in locations where testing would not otherwise have been available. An initial TST visit was approximately 6-15 minutes, and follow-up visits were typically 5 minutes or less. The most common reason reported for not testing was lack of employer support (61%). The strongest association with testing was training requirement by employer (odds ratio [OR], 20.4; 95% CI 4.2-99.2), followed by strong confidence in their ability to perform the TST (OR, 14.2; 95% CI 2.8-71.2).
CONCLUSION: PPTST is positively perceived by New Mexico pharmacists and provides testing in non-urban areas where access may be low. Survey respondents were confident in their ability to perform the TST and report that testing typically takes less than 15 minutes. The main hindrance to implementing PPTST was lack of employer support.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30274884      PMCID: PMC8083186          DOI: 10.1016/j.japh.2018.08.010

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  14 in total

1.  Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers.

Authors:  Sumanth Gandra; William S Scott; Vijaya Somaraju; Huaping Wang; Suzanne Wilton; Michelle Feigenbaum
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10-27       Impact factor: 3.254

2.  Evaluation of a pharmacist-performed tuberculosis testing initiative in New Mexico.

Authors:  Bernadette Jakeman; Brittni Gross; Diana Fortune; Sarrah Babb; Dale Tinker; Amy Bachyrycz
Journal:  J Am Pharm Assoc (2003)       Date:  2015 May-Jun

3.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

4.  Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.

Authors:  Abby M Bailey; Daniel P Wermeling
Journal:  Ann Pharmacother       Date:  2014-02-12       Impact factor: 3.154

5.  Pharmacists' perspectives on HIV testing in community pharmacies.

Authors:  Priscilla T Ryder; Beth E Meyerson; Kelsey C Coy; Christiana D J von Hippel
Journal:  J Am Pharm Assoc (2003)       Date:  2013 Nov-Dec

Review 6.  Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

Authors:  Madhukar Pai; Alice Zwerling; Dick Menzies
Journal:  Ann Intern Med       Date:  2008-06-30       Impact factor: 25.391

7.  HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection.

Authors:  Paul J Weidle; Shirley Lecher; Linda W Botts; LaDawna Jones; David H Spach; Jorge Alvarez; Rhondette Jones; Vasavi Thomas
Journal:  J Am Pharm Assoc (2003)       Date:  2014 Sep-Oct

8.  Tuberculin skin testing by pharmacists in a grocery store setting.

Authors:  Nancy Hecox
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Jan-Feb

Review 9.  Public health in community pharmacy: a systematic review of pharmacist and consumer views.

Authors:  Claire E Eades; Jill S Ferguson; Ronan E O'Carroll
Journal:  BMC Public Health       Date:  2011-07-21       Impact factor: 3.295

Review 10.  The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.

Authors:  Rein M G J Houben; Peter J Dodd
Journal:  PLoS Med       Date:  2016-10-25       Impact factor: 11.069

View more
  1 in total

1.  Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department.

Authors:  Bernadette Jakeman; Stefanie J Logothetis; Melissa H Roberts; Amy Bachyrycz; Diana Fortune; Matthew E Borrego; Julianna Ferreira; Marcos Burgos
Journal:  Prev Chronic Dis       Date:  2020-02-13       Impact factor: 2.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.